S&P 500
(0.18%) 5 257.80 points
Dow J
(0.16%) 39 824 points
Nasdaq
(-0.08%) 16 386 points
Oil
(2.02%) $82.99
Gas
(1.75%) $1.748
Gold
(1.24%) $2 240.20
Silver
(0.89%) $24.97
Platinum
(1.34%) $921.85
USD/EUR
(0.39%) $0.927
USD/NOK
(0.81%) $10.86
USD/GBP
(0.13%) $0.792
USD/RUB
(0.14%) $92.57

Realtime updates for Magenta Therapeutics Inc [MGTA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated11 Sep 2023 @ 16:00

-7.74% $ 0.700

Live Chart Being Loaded With Signals

Commentary (11 Sep 2023 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases...

Stats
Today's Volume 375 912
Average Volume 247 981
Market Cap 42.44M
EPS $0 ( 2024-03-21 )
Next earnings date ( $0 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.608
ATR14 $0.0360 (5.15%)
Insider Trading
Date Person Action Amount type
2023-09-29 Fairmount Funds Management Llc Buy 24 670 Common Stock
2023-09-26 Fairmount Funds Management Llc Buy 30 000 Common Stock
2023-09-22 Randhawa Simrat Buy 2 000 Common Stock
2023-09-21 Randhawa Simrat Buy 2 000 Common Stock
2023-09-19 Fairmount Funds Management Llc Buy 30 000 Common Stock
INSIDER POWER
-64.38
Last 94 transactions
Buy: 3 902 024 | Sell: 4 691 992

Volume Correlation

Long: -0.22 (neutral)
Short: -0.86 (strong negative)
Signal:(36.83) Neutral

Magenta Therapeutics Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Magenta Therapeutics Inc Correlation - Currency/Commodity

The country flag 0.33
( neutral )
The country flag 0.06
( neutral )
The country flag 0.00
( neutral )
The country flag 0.46
( neutral )
The country flag -0.50
( neutral )
The country flag -0.52
( weak negative )

Magenta Therapeutics Inc Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-23.05
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-3.78
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.030
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-8.21

Financial Reports:

No articles found.

Magenta Therapeutics Inc

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators